The platinum-based treatments for advanced non-small cell lung cancer, is low/negative ERCC1 expression better than high/positive ERCC1 expression? A meta-analysis-Reference-Cited by-同舟云学术

The platinum-based treatments for advanced non-small cell lung cancer, is low/negative ERCC1 expression better than high/positive ERCC1 expression? A meta-analysis

Published:2010-10 Issue:1 Volume:70 Page:63-70
ISSN:0169-5002
Container-title:Lung Cancer
language:en
Short-container-title:Lung Cancer

Author:

Chen Sufeng,Zhang Jie,Wang Rui,Luo Xiaoyang,Chen Haiquan

Publisher

Elsevier BV

Subject

Cancer Research,Pulmonary and Respiratory Medicine,Oncology

Reference52 articles.

1. Global Cancer Facts and Figures 2007;Garcia,2007

2. Cancer statistics, 2009;Jemal;CA Cancer J Clin,2009

3. Clinical practice guidelines for the treatment of unresectable non-small-cell lung cancer. Adopted on May 16, 1997 by the American Society of Clinical Oncology;J Clin Oncol,1997

4. American Society of Clinical Oncology treatment of unresectable non-small-cell lung cancer guideline: update 2003;Pfister;J Clin Oncol,2004

5. Randomized phase II three-arm trial with three platinum-based doublets in metastatic non-small-cell lung cancer. An Italian Trials in Medical Oncology Study;Bidoli;Ann Oncol,2007

Cited by 69 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Small Molecule Antagonists of the DNA Repair ERCC1/XPA Protein‐Protein Interaction;ChemMedChem;2024-03-05

2. Combined Serum ALBUMIN with Neutrophil-to-Lymphocyte Ratio Predicts the Prognosis of Biliary Tract Cancer after Curative Resection;Cancers;2023-11-19

3. Therapeutic implications of germline vulnerabilities in DNA repair for precision oncology;Cancer Treatment Reviews;2022-03

4. Evidence for diverse prognosis in high-grade serous ovarian carcinoma: solid, pseudoendometrioid, and transitional-like; so-called Â“set morphologyÂ” and progesterone receptor status;Turkish Journal of Pathology;2022

5. Synergistic effects of olaparib combined with ERCC1 on the sensitivity of cisplatin in non‑small cell lung cancer;Oncology Letters;2021-03-10